Sunshine Biopharma (SBFMW) Accumulated Depreciation & Amortization (2016 - 2025)
Historic Accumulated Depreciation & Amortization for Sunshine Biopharma (SBFMW) over the last 8 years, with Q3 2025 value amounting to $462469.0.
- Sunshine Biopharma's Accumulated Depreciation & Amortization changed N/A to $462469.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $462469.0, marking a year-over-year change of. This contributed to the annual value of $336533.0 for FY2024, which is 7712.64% up from last year.
- According to the latest figures from Q3 2025, Sunshine Biopharma's Accumulated Depreciation & Amortization is $462469.0.
- Sunshine Biopharma's Accumulated Depreciation & Amortization's 5-year high stood at $462469.0 during Q3 2025, with a 5-year trough of $12741.0 in Q4 2021.
- Moreover, its 5-year median value for Accumulated Depreciation & Amortization was $336533.0 (2024), whereas its average is $258386.9.
- In the last 5 years, Sunshine Biopharma's Accumulated Depreciation & Amortization surged by 65506.1% in 2023 and then surged by 7712.64% in 2024.
- Over the past 5 years, Sunshine Biopharma's Accumulated Depreciation & Amortization (Quarter) stood at $12741.0 in 2021, then skyrocketed by 97.5% to $25163.0 in 2022, then surged by 655.06% to $189996.0 in 2023, then skyrocketed by 77.13% to $336533.0 in 2024, then soared by 37.42% to $462469.0 in 2025.
- Its Accumulated Depreciation & Amortization stands at $462469.0 for Q3 2025, versus $412626.0 for Q2 2025 and $369180.0 for Q1 2025.